T. Gargi

发表

Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study.

P. Bachmann, O. Trédan, T. Bachelot, 2010, Clinical nutrition.

Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma.

J. Blay, F. Berger, B. Coiffier, 2004, The hematology journal : the official journal of the European Haematology Association.

Event-Free Survival at 12 Months (EFS12) from Diagnosis Is a Robust Endpoint for Disease-Related Survival in Patients with Follicular Lymphoma in the Immunochemotherapy Era

J. Cerhan, A. Feldman, T. Habermann, 2014 .

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

J. Bourhis, S. Koscielny, P. Biron, 2006, Leukemia.

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

J. Cerhan, T. Habermann, S. Ansell, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Time-to-event analysis with artificial neural networks: An integrated analytical and rule-based study for breast cancer

Paulo J. G. Lisboa, Valérie Bourdès, Stéphane Bonnevay, 2007, 2007 International Joint Conference on Neural Networks.

Combination of rituximab with chemotherapy in diffuse large B‐cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication

J. Blay, P. Biron, C. Sebban, 2008, Hematological oncology.

Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival

Pierre Biron, Sylvie Chabaud, Thérèse Gargi, 2009, Annals of Hematology.

Impact of the introduction of rituximab in first‐line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long‐term follow‐up

P. Biron, C. Sebban, C. Chassagne‐Clément, 2015, Hematological oncology.

Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis

F. Bertucci, P. Finetti, O. Trédan, 2012, Oncogene.

Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy Who Are Alive and Progression Free 12 Months After Diagnosis Have a Subsequent Overall Survival Similar to That of the General Population

J. Cerhan, T. Habermann, S. Slager, 2012 .

Development of a Rule Based Prognostic Tool for HER 2 Positive Breast Cancer Patients

P.J.G. Lisboa, M.S.H. Aung, T.A. Etchells, 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

Evaluation in the Context of Daily Practice of Follicular Lymphoma patients' Outcome Before and After Approval of Rituximab in First Line Therapy in This Indication: Results of a Retrospective Analysis of 247 Unselected Patients with a 5-Year Median of Follow-up,

J. Blay, P. Biron, C. Sebban, 2011 .

Comparison of Artificial Neural Network with Logistic Regression as Classification Models for Variable Selection for Prediction of Breast Cancer Patient Outcomes

Valérie Bourdès, Stéphane Bonnevay, Paolo Lisboa, 2010, Adv. Artif. Neural Syst..

Time-to-event analysis with artificial neural networks: An integrated analytical and rule-based study for breast cancer

T. Bachelot, D. Pérol, V. Bourdès, 2007, 2007 International Joint Conference on Neural Networks.